Effectiveness of extracorporeal membrane oxygenation (ECMO) therapy in critically patients with COVID-19
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/26388 |
Resumo: | Severe cases of COVID-19 may require oxygen support therapies, such as the use of Extracorporeal Oxygenation Membrane (ECMO) and mechanical ventilation (MV). ECMO is a therapy used for temporary support in cases of pulmonary and/or cardiac function failure. This integrative review aimed to assess the scientific literature on the effectiveness of ECMO in critically patients with COVID-19. Articles collected from PubMed, published from December 2019 to June 2021, using the descriptors "COVID-19" and "ECMO" were included in this review. Articles that did not present results on the assessment of the relation between ECMO and COVID-19 and those that fell into the category of letter to the editor model or narrative reviews were excluded. For an integrated discussion, the articles were grouped in a table containing title, objective, method, methodology, results and conclusion. 36 articles were included for the integrative analysis. It was possible to evidence a greater efficacy of ECMO in younger patients (< 71 years), with greater disease severity and in those with comorbidities. However, the therapy has certain types of complications, such as a high risk of thrombosis and circuit failure, which can lead to an unsuccessful weaning from ECMO. ECMO therapy can help critically patients with COVID-19 in certain conditions, although it may increase the risk of thrombosis, and further studies are needed for better clarification. |
id |
UNIFEI_e1234a098a5790d17605e3da4d9f1c7b |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/26388 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Effectiveness of extracorporeal membrane oxygenation (ECMO) therapy in critically patients with COVID-19 Eficacia de la terapia de oxigenación por membrana extracorpórea (ECMO) en pacientes críticos con COVID-19 Efetividade da terapia por oxigenação de membrana extracorpórea (ECMO) em pacientes críticos com COVID-19COVID-19Extracorporeal Membrane OxygenationEficácia.COVID-19Oxigenación por Membrana ExtracorpóreaEficacia.COVID-19Oxigenação por Membrana ExtracorpóreaEfficiency.Severe cases of COVID-19 may require oxygen support therapies, such as the use of Extracorporeal Oxygenation Membrane (ECMO) and mechanical ventilation (MV). ECMO is a therapy used for temporary support in cases of pulmonary and/or cardiac function failure. This integrative review aimed to assess the scientific literature on the effectiveness of ECMO in critically patients with COVID-19. Articles collected from PubMed, published from December 2019 to June 2021, using the descriptors "COVID-19" and "ECMO" were included in this review. Articles that did not present results on the assessment of the relation between ECMO and COVID-19 and those that fell into the category of letter to the editor model or narrative reviews were excluded. For an integrated discussion, the articles were grouped in a table containing title, objective, method, methodology, results and conclusion. 36 articles were included for the integrative analysis. It was possible to evidence a greater efficacy of ECMO in younger patients (< 71 years), with greater disease severity and in those with comorbidities. However, the therapy has certain types of complications, such as a high risk of thrombosis and circuit failure, which can lead to an unsuccessful weaning from ECMO. ECMO therapy can help critically patients with COVID-19 in certain conditions, although it may increase the risk of thrombosis, and further studies are needed for better clarification. Los casos graves de COVID-19 pueden requerir terapias de apoyo de oxígeno, como el uso de oxigenación por membrana extracorpórea (ECMO) y ventilación mecánica (VM). ECMO es una terapia utilizada como soporte temporal en casos de falla de la función pulmonar y/o cardíaca. Esta revisión integradora tuvo como objetivo evaluar la literatura científica sobre la efectividad de ECMO en pacientes críticos con COVID-19. En esta revisión se incluyeron artículos recopilados de PubMed, publicados entre diciembre de 2019 y junio de 2021, utilizando los descriptores "COVID-19" y "ECMO". Se excluyeron los artículos que no presentaron resultados sobre la evaluación de la relación de ECMO con el COVID-19 y aquellos que encajan en la categoría de modelo de carta al editor o reseñas narrativas. Para una discusión integrada, los artículos fueron agrupados en una tabla que contenía título, objetivo, método, metodología, resultados y conclusión. Para el análisis integrador se incluyeron 36 artículos. Se pudo evidenciar una mayor efectividad de ECMO en pacientes más jóvenes (< 71 años), con mayor gravedad de la enfermedad y en aquellos con comorbilidades. Sin embargo, la terapia tiene ciertos tipos de complicaciones, como un alto riesgo de trombosis y fallas en el circuito, que pueden conducir a un destete ECMO fallido. La terapia ECMO puede ayudar a los pacientes críticos con COVID-19 en ciertas condiciones, aunque puede aumentar el riesgo de trombosis, y se necesitan más estudios para obtener más aclaraciones.Casos graves de COVID-19 podem necessitar de terapias de suporte de oxigênio, como a utilização de Membrana de Oxigenação Extracorpórea (ECMO) e ventilação mecânica (VM). A ECMO é uma terapia usada para suporte temporário em casos de falência da função pulmonar e/ou cardíaca. Esta revisão integrativa objetivou avaliar a literatura científica sobre a efetividade da ECMO em pacientes críticos com COVID-19. Foram incluídos na presente revisão artigos coletados do PubMed, publicados no período de dezembro de 2019 a junho de 2021, utilizando-se os descritores “COVID-19” e “ECMO”. Foram excluídos artigos que não apresentavam resultados sobre a avaliação da relação da ECMO com a COVID-19 e os que se enquadravam na categoria de modelo de carta ao editor ou revisões narrativas. Para a discussão de forma integrada, os artigos foram agrupados em uma tabela contendo título, objetivo, método, metodologia, resultados e conclusão. Foram incluídos para a análise integrativa, 36 artigos. Foi possível evidenciar uma maior eficácia da ECMO nos pacientes mais jovens (< 71 anos), com maior gravidade da doença e nos que apresentavam comorbidades. Porém, a terapia apresenta certos tipos de complicações, como alto risco de trombose e falhas no circuito, o que podem levar a um desmame malsucedido da ECMO. A terapia com ECMO pode auxiliar pacientes graves com COVID-19 em determinadas condições, embora possa aumentar o risco de trombose, sendo necessários mais estudos para um melhor esclarecimento. Research, Society and Development2022-02-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2638810.33448/rsd-v11i3.26388Research, Society and Development; Vol. 11 No. 3; e5911326388Research, Society and Development; Vol. 11 Núm. 3; e5911326388Research, Society and Development; v. 11 n. 3; e59113263882525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/26388/23001Copyright (c) 2022 Stephanie Zambrano Lavezzo; Samantha Ellen Beltrame; Carolina Heitmann Mares Azevedo Ribeiro; Ana Cristina Lo Pretehttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessLavezzo, Stephanie Zambrano Beltrame, Samantha Ellen Ribeiro, Carolina Heitmann Mares Azevedo Prete, Ana Cristina Lo 2022-03-09T13:44:38Zoai:ojs.pkp.sfu.ca:article/26388Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:44:26.985873Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Effectiveness of extracorporeal membrane oxygenation (ECMO) therapy in critically patients with COVID-19 Eficacia de la terapia de oxigenación por membrana extracorpórea (ECMO) en pacientes críticos con COVID-19 Efetividade da terapia por oxigenação de membrana extracorpórea (ECMO) em pacientes críticos com COVID-19 |
title |
Effectiveness of extracorporeal membrane oxygenation (ECMO) therapy in critically patients with COVID-19 |
spellingShingle |
Effectiveness of extracorporeal membrane oxygenation (ECMO) therapy in critically patients with COVID-19 Lavezzo, Stephanie Zambrano COVID-19 Extracorporeal Membrane Oxygenation Eficácia. COVID-19 Oxigenación por Membrana Extracorpórea Eficacia. COVID-19 Oxigenação por Membrana Extracorpórea Efficiency. |
title_short |
Effectiveness of extracorporeal membrane oxygenation (ECMO) therapy in critically patients with COVID-19 |
title_full |
Effectiveness of extracorporeal membrane oxygenation (ECMO) therapy in critically patients with COVID-19 |
title_fullStr |
Effectiveness of extracorporeal membrane oxygenation (ECMO) therapy in critically patients with COVID-19 |
title_full_unstemmed |
Effectiveness of extracorporeal membrane oxygenation (ECMO) therapy in critically patients with COVID-19 |
title_sort |
Effectiveness of extracorporeal membrane oxygenation (ECMO) therapy in critically patients with COVID-19 |
author |
Lavezzo, Stephanie Zambrano |
author_facet |
Lavezzo, Stephanie Zambrano Beltrame, Samantha Ellen Ribeiro, Carolina Heitmann Mares Azevedo Prete, Ana Cristina Lo |
author_role |
author |
author2 |
Beltrame, Samantha Ellen Ribeiro, Carolina Heitmann Mares Azevedo Prete, Ana Cristina Lo |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Lavezzo, Stephanie Zambrano Beltrame, Samantha Ellen Ribeiro, Carolina Heitmann Mares Azevedo Prete, Ana Cristina Lo |
dc.subject.por.fl_str_mv |
COVID-19 Extracorporeal Membrane Oxygenation Eficácia. COVID-19 Oxigenación por Membrana Extracorpórea Eficacia. COVID-19 Oxigenação por Membrana Extracorpórea Efficiency. |
topic |
COVID-19 Extracorporeal Membrane Oxygenation Eficácia. COVID-19 Oxigenación por Membrana Extracorpórea Eficacia. COVID-19 Oxigenação por Membrana Extracorpórea Efficiency. |
description |
Severe cases of COVID-19 may require oxygen support therapies, such as the use of Extracorporeal Oxygenation Membrane (ECMO) and mechanical ventilation (MV). ECMO is a therapy used for temporary support in cases of pulmonary and/or cardiac function failure. This integrative review aimed to assess the scientific literature on the effectiveness of ECMO in critically patients with COVID-19. Articles collected from PubMed, published from December 2019 to June 2021, using the descriptors "COVID-19" and "ECMO" were included in this review. Articles that did not present results on the assessment of the relation between ECMO and COVID-19 and those that fell into the category of letter to the editor model or narrative reviews were excluded. For an integrated discussion, the articles were grouped in a table containing title, objective, method, methodology, results and conclusion. 36 articles were included for the integrative analysis. It was possible to evidence a greater efficacy of ECMO in younger patients (< 71 years), with greater disease severity and in those with comorbidities. However, the therapy has certain types of complications, such as a high risk of thrombosis and circuit failure, which can lead to an unsuccessful weaning from ECMO. ECMO therapy can help critically patients with COVID-19 in certain conditions, although it may increase the risk of thrombosis, and further studies are needed for better clarification. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-02-12 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/26388 10.33448/rsd-v11i3.26388 |
url |
https://rsdjournal.org/index.php/rsd/article/view/26388 |
identifier_str_mv |
10.33448/rsd-v11i3.26388 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/26388/23001 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 11 No. 3; e5911326388 Research, Society and Development; Vol. 11 Núm. 3; e5911326388 Research, Society and Development; v. 11 n. 3; e5911326388 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052762821754880 |